Startseite>>Signaling Pathways>> Angiogenesis>> BTK>>Btk inhibitor 2

Btk inhibitor 2 (Synonyms: BGB-3111 analog)

Katalog-Nr.GC32007

Btk-Inhibitor 2 (BGB-3111-Analog) ist ein Bruton-Tyrosinkinase (BTK)-Inhibitor, der aus dem Patent US 20170224688 A1 extrahiert wurde.

Products are for research use only. Not for human use. We do not sell to patients.

Btk inhibitor 2 Chemische Struktur

Cas No.: 1558036-85-3

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
86,00 $
Auf Lager
5mg
78,00 $
Auf Lager
10mg
117,00 $
Auf Lager
50mg
441,00 $
Auf Lager
100mg
531,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Btk inhibitor 2 is a Bruton's tyrosine kinase (BTK) inhibitor extracted from patent US 20170224688 A1.

[1]. Cecile M. Krejsa. Methods of Using BTK Inhibitors to Treat Dermatoses. US 20170224688 A1.

Bewertungen

Review for Btk inhibitor 2

Average Rating: 5 ★★★★★ (Based on Reviews and 17 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Btk inhibitor 2

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.